The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Increase In Market Value Is Predicted For The Rare Disease Diagnostics Market During The 2026–2030 Period?
The rare disease diagnostics market has demonstrated strong growth in recent years. This market is set to expand from $38.14 billion in 2025 to $41.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The growth observed in prior periods can be attributed to the wider availability of genetic testing, increased awareness of rare diseases among medical professionals, a rise in the application of molecular diagnostics, the proliferation of specialized diagnostic laboratories, and enhanced access to advanced imaging technologies.
The rare disease diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $62.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. Several factors are expected to drive this growth throughout the forecast period, including the increasing acceptance of personalized medicine, augmented investments in genomics research, a heightened need for the early detection of rare diseases, the expanded integration of AI-powered diagnostic instruments, and the broadened scope of rare disease screening initiatives. Key trends anticipated during this period encompass the greater embrace of next-generation sequencing diagnostics, the increasing application of multi-gene panel testing, the deeper incorporation of sophisticated imaging techniques in rare disease diagnosis, the establishment of more centralized rare disease testing facilities, and a stronger emphasis on prompt and precise diagnosis.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12651&type=smp
Which Growth Factors Are Strengthening The Rare Disease Diagnostics Market Landscape?
The increasing prevalence of rare diseases is projected to fuel the expansion of the rare disease diagnostics market. Rare diseases are medical conditions that affect a small portion of the population compared to more common illnesses, often requiring specific diagnostic tools for early and accurate detection. Rare disease diagnostics are instrumental in improving disease management, enabling the identification of potential therapeutics, and reducing unneeded or harmful treatments, thus fostering more effective patient care. For instance, in March 2025, according to Kidney Research UK, an UK-based kidney disease charity, the rare kidney disease landscape currently includes over 150 distinct conditions, impacting an estimated 70 per 100,000 people, predominantly originating from genetic alterations. Therefore, the rise in rare disease incidence is a primary driver for the growth of the rare disease diagnostics market.
How Does Segment Analysis Break Down The Rare Disease Diagnostics Market Structure?
The rare disease diagnostics market covered in this report is segmented –
1) By Test Type: Genetic Test, General Lab Test, Imaging Test
2) By Technology: Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays
3) By Sample Type: Deoxyribonucleic Acid (DNA) Sample, Buccal Swab Sample, Blood, Saliva
4) By Disease Type: Gastroenterology Disease, Endocrine And Metabolism Disorders Disease, Hematology And Oncology Disease, Dermatology Disease, Cardiovascular Disorders, Neurology Disease
5) By End User: Hospital Laboratories, Diagnostics Laboratories, Genetic Testing Laboratories, Cancer Research Laboratories
Subsegments:
1) By Genetic Test: Whole Genome Sequencing, Targeted Gene Panels, Exome Sequencing, Carrier Testing
2) By General Lab Test: Blood Tests, Biochemical Assays, Urine Tests, Cytogenetic Tests
3) By Imaging Test: MRI (Magnetic Resonance Imaging), CT (Computed Tomography) Scans, Ultrasound, X-Rays
What Trends Are Influencing The Future Of The Rare Disease Diagnostics Market?
Companies operating within the rare disease community app market are concentrating on developing advanced solutions, such as natural language processing (NLP) analytics, to enhance patient engagement, streamline communication with healthcare providers, and bolster disease-management support. Natural language processing (NLP) analytics refers to artificial intelligence-driven methodologies that analyze, interpret, and condense human language to generate actionable health insights for patients and clinicians. For example, in December 2024, Know Rare, Inc., a UK-based health technology company, launched the HealthStoryAI app. This app includes AI-generated summaries of patient-reported experiences, structured symptom and daily health tracking, and personalized insight dashboards, which collectively aid patients and healthcare providers in identifying meaningful health patterns and empowering individuals with rare diseases to better manage their conditions.
Who Are The Businesses Driving Activity In The Rare Disease Diagnostics Market?
Major companies operating in the rare disease diagnostics market are Thermo Fisher Scientific Inc., Roche Diagnostics, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Sanofi Genzyme, Illumina Inc., Bio Rad Laboratories Inc., Qiagen NV, OPKO Health Inc., Natera Inc., Invitae Corporation, BGI Genomics Co. Ltd., 23andMe Holding Co., Ambry Genetics Corporation, Centogene N.V., GENEWIZ Inc., Blueprint Genetics Inc., Oxford Gene Technology Limited, Strand Life Sciences Pvt. Ltd., RareCyte Inc., Sophia Genetics SA, Foundation Medicine Inc.
Access The Complete Rare Disease Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report
Which Region Contributes The Most To The Rare Disease Diagnostics Market?
North America was the largest region in the rare disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Rare Disease Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12651&type=smp
Browse Through More Reports Similar to the Global Rare Disease Diagnostics Market 2026, By The Business Research Company
Rare Disease Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report
Rare Diseases Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report
Rare Inflammatory Disease Treatment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model